Yamauchi T, Asakura T, Shingaki T, Oura T, et al. Efficacy and safety of once-weekly tirzepatide in Japanese participants with type 2 diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT-2 trial. Diabetes Obes Metab 2025 Jun 9. doi: 10.1111/dom.16500.
PMID: 40490415